Cholinergic drugs play a pivotal role in pharmacodynamics by modulating the activity of the neurotransmitter acetylcholine within the body's cholinergic system. These drugs exert their effects by interacting with cholinergic receptors, namely muscarinic and nicotinic receptors. Muscarinic receptors are predominantly found in various organs, including the heart, smooth muscles, and glands, while nicotinic receptors are present in the neuromuscular junctions. Stimulation of muscarinic receptors by cholinergic drugs leads to diverse physiological responses, such as increased glandular secretion, smooth muscle contraction, and a decrease in heart rate. On the other hand, activation of nicotinic receptors results in neuromuscular transmission and subsequent skeletal muscle contraction. Pharmacodynamics of cholinergic drugs involve mimicking or enhancing the effects of acetylcholine, ultimately influencing processes like gastrointestinal motility, respiratory function, and cardiovascular regulation. Understanding these pharmacological dynamics is crucial for therapeutic applications, such as in the treatment of conditions like myasthenia gravis or for promoting gastrointestinal motility after surgery. However, careful consideration is required due to potential side effects, including bradycardia, bronchoconstriction, and gastrointestinal disturbances.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India